Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where János Szulágyi is active.

Publication


Featured researches published by János Szulágyi.


Archive | 2000

Process for preparing (1R,2S,4R)-(-)-2-[(2'-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof

Gyula Lukács; Gyula Simig; Tibor Mezei; Zoltan Budai; Márta Porcs-Makkay; György Krasznai; Kalman Nagy; Györgyi Donáth Vereczkey; Tibor Szabo; Norbert Nemeth; János Szulágyi


Archive | 2008

Process for the preparation of pharmaceutical intermediates

Tibor Mezei; Gyula Lukács; Enikö Molnár; Jozsef Barkoczy; Balázs Volk; Márta Porcs-Makkay; János Szulágyi; Mária Vajjon


Archive | 2002

Improved process for the preparation of 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl}-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one

László Pongó; Jozsef Reiter; Gyula Simig; Gábor Berecz; György Clementis; Péter Slégel; János Szulágyi; László Koncz; Donáth Györgyi Vereczkeyné; Kalman Nagy; Gyuláné Körtvélyessy


Archive | 2001

High purity (1R, 2S, 4R) -(-) -2- [ (2' -{N,N-dimethylamino} -ethoxy) ] -2- [phenyl] -1, 7,7 -tri - [methyl] -bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof and a process for the preparation of these compounds as well as medicaments containing 1 or more of these compounds and their use

Gyula Lukács; Gyula Simig; Tibor Mezei; Zoltan Budai; Márta Porcs-Makkay; György Krasznai; Kalman Nagy; Györgyi Donáth Vereczkey; Tibor Szabo; Norbert Nemeth; János Szulágyi


Archive | 2000

High purity (1R,2S,4R)-(-)-2-[(2'-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof

Gyula Lukács; Gyula Simig; Tibor Mezei; Zoltan Budai; Márta Porcs-Makkay; György Krasznai; Kalman Nagy; Györgyi Donáth Vereczkey; Tibor Szabo; Norbert Nemeth; János Szulágyi


Archive | 2008

Process for the preparation of pharmaceutical i nterm ediates

Tibor Mezei; Gyula Lukács; Enikö Molnár; Jószef Barkóczy; Balázs Volk; Márta Porcs-Makkay; János Szulágyi; Mária Vajjon


Archive | 2002

Process for the preparation of 3-{2-'4- (6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl!ethyl}-6,7,8,9-tetrahydro-2-methyl-4h-pyrido'1,2-methyl-4h-pyrido',2-a!pyrimidin-4-one

László Pongó; Jozsef Reiter; Gyula Simig; Gábor Berecz; György Clementis; Péter Slégel; János Szulágyi; László Koncz; Gyorgyi Vereczkeyne Donath; Kalman Nagy; Gyuláné Körtvélyessy


Archive | 2000

High purity (1R, 2S, 4R)-(-)-2-[(2'-(N,N-dimethylamino)-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof, process for the preparation of these compounds and medicaments containing them

Zoltan Budai; Gyoergy Krasznai; Gyula Lukács; Tibor Mezei; Kalman Nagy; Norbert Nemeth; Márta Porcs-Makkay; Gyula Simig; Tibor Szabo; János Szulágyi; Donath Gyoergyi Vereczkeyne


Archive | 2008

PROCESS FOR THE PREPARATION OF PHARMACEUTICAL INTERMEDIATE

Tibor Mezei; Gyula Lukács; Enikö Molnár; Jozsef Barkoczy; Balázs Volk; Márta Porcs-Makkay; János Szulágyi; Mária Vajjon


Archive | 2008

Procédé de préparation d'intermédiaires pharmaceutiques

Tibor Mezei; Gyula Lukács; Enikö Molnár; Jozsef Barkoczy; Balázs Volk; Márta Porcs-Makkay; János Szulágyi; Mária Vajjon

Collaboration


Dive into the János Szulágyi's collaboration.

Researchain Logo
Decentralizing Knowledge